The Over-The-Counter (OTC) Drug Market is being driven by New product launches in global over-the-counter (OTC) drug market
The Over-The-Counter (OTC) Drug Market is expected to grow at a CAGR of 6% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 59.6 billion. The global geriatric population is projected to expand significantly, with an anticipated increase of approximately 1.5 billion individuals aged 65 years and above by 2050, as per the World Health Organization (WHO). This demographic trend is particularly noticeable in developing countries, including China, India, Japan, Bangladesh, and South Korea. Geriatric individuals often grapple with various health issues such as cancer, diabetes, high blood pressure, and blood sugar imbalances. To manage these conditions, they frequently require medication at specified intervals. Over-the-counter (OTC) drugs are sometimes preferred by the elderly population to alleviate their symptoms, making the OTC drug market a crucial sector in addressing the healthcare needs of the aging population.
Get more information on Over-The-Counter (OTC) Drug Market by requesting a sample report
The market is segmented based on
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
However, the market also witnesses some limitations, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Market Scope |
|
Report Coverage |
Details |
Page number |
228 |
Base year |
2024 |
Historic period |
2019-2023 |
Forecast period |
2025-2029 |
Growth momentum & CAGR |
Accelerate at a CAGR of 6% |
Market growth 2025-2029 |
USD 59.6 billion |
Market structure |
fragmentation |
YoY growth 2024-2025(%) |
5.7 |
Key countries |
China, Germany, Japan, US, Canada, UK, France, India, Italy, and Mexico |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Find out which segment is leading the market by accessing the free PDF report
The Over-The-Counter (OTC) Drug Market encompasses a wide range of treatments for both chronic and acute conditions. Efficacy, dosage guidelines, and treatment protocols are crucial for ensuring optimal patient outcomes. Side effects, drug monitoring, and adverse event reporting are essential for managing risks. Public health and disease management are key focus areas, particularly for chronic conditions. Patient education, health literacy, and consumer behavior play significant roles in effective use of OTC drugs. Generic drug approval, post-market surveillance, and intellectual property rights impact market dynamics. Health insurance, medication assistance programs, and healthcare access influence consumer access to OTC drugs. Global health and international regulations shape the OTC drug landscape. Personalized medicine and targeted therapies offer new opportunities for product differentiation and brand loyalty. Product lifecycle management is crucial for maximizing revenue and managing risks throughout a product's life.
The Over-The-Counter (OTC) drug market encompasses a range of products, including cough suppressants, sleep aids, dietary supplements, herbal remedies, homeopathic remedies, and first-aid kits. These offerings fall under the broader umbrella of the global pharmaceuticals market, which comprises entities involved in Research and Development (R&D) or production of generic drugs, non-generic drugs, and veterinary drugs. According to Technavio, the healthcare market size is determined by the collective revenue generated by manufacturers and providers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services. The expansion of the global pharmaceuticals market will be fueled by several key factors, including the increasing global population aging. By 2050, approximately one-quarter of the US population and by 2030 in Europe, are projected to be over the age of 60 years.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted